We report acute antibody responses to SARS-CoV-2 in 285 patients with COVID-19. Within
19 days after symptom onset, 100% of patients tested positive for antiviral immunoglobulin-G …

Background We aim to investigate the profile of acute antibody response in COVID-19 patients,
and provide proposals for the usage of antibody test in clinical practice. Methods A multi-…

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel β-coronavirus,
causes severe pneumonia and has spread throughout the globe rapidly. The …

Background & Aims Current antiviral therapies help keep HBV under control, but they are
not curative, as they are unable to eliminate the intracellular viral replication intermediate …

Purpose: To characterize the functional role of SIRT6 in hepatocellular carcinoma (HCC).
Experimental Design: The expression of SIRT6 in 60 paired paraffin-embedded HCC tissues …

Chronic hepatitis B virus (HBV) infection is a major risk factor for liver cirrhosis and hepatocellular
carcinoma. Nevertheless, the molecular mechanism of HBV replication remains elusive…

Invasion and metastasis are the predominant causes of lethal outcomes in patients with
hepatocellular carcinoma (HCC). However, the molecular mechanism underlying the invasive or …

Background and Aims The mechanism underlying HCC metastasis remains unclear, many
oncogenes are known to regulate this process. However, the role of alternative splicing (AS) …

Hepatitis B virus (HBV) infection remains a major health problem worldwide. Maintenance
of the covalently closed circular DNA (cccDNA), which serves as a template for HBV RNA …

Background/Aim The hepatitis B virus (HBV) infection is accompanied by the induction of
oxidative stress, especially mediated by HBV X protein (HBx). Oxidative stress has been …